DECISION SCIENCE FOR LIFE SCIENCES
Decision models and execution discipline for life science leaders navigating complexities across product innovation, portfolio management, and M&A.
Built on operator-led insight and value creation from idea to market.
THE DECISIONS
Business Evolution Lifecycle
For decisions that cannot be deferred, delegated, or reversed without material risk or cost.
Revenue impact
Strategy
Commercial Viability
Translate market insight into actionable asset roadmaps that create new value.
NPIs launched
Portfolio
Asset Prioritization
Maximize pipeline value through disciplined trade-offs in capital allocation.
Integrations
M&A
Due Diligence and Integration
Validate external targets through rigorous diligence to secure post-merger value.
Global P&L impact across Sartorius, MilliporeSigma, and advisory.
THE FRAMEWORKS
Architect strategy
Identify high-value opportunities and characterize commercial and technical risks.
Anchor ambition.
Rationalize portfolio
Benchmark and prioritize pipeline assets to maximize capital efficiency.
Optimize returns.
Pressure-test thesis
Quantify synergies and critical failure modes before final deal commitment.
Realize value.
ENGAGEMENT TRIGGERS
Strategic Readiness
Before deployment
Establish governance and quantify risk before investing capital into major R&D programs, commercial projects, or complex integrations.
Protect capital.
Project Recovery
After disruption
Deliver objective oversight and intervention when initiatives stall, miss critical milestones, or invalidate core assumptions. Reset the trajectory.
Restore momentum.
Me-too pipelines
Delayed launches
Missed synergies
Competitor blue oceans
For life-science leaders making decisions that shape the next growth curve.